COSMOS Pharmaceutical (COSMOS Pharmaceutical) Accounts Payable & Accrued Expense : $1,101 Mil (As of Feb. 2024)

View and export this data going back to 2014. Start your Free Trial

What is COSMOS Pharmaceutical Accounts Payable & Accrued Expense?

COSMOS Pharmaceutical's quarterly accounts payable & accrued expense declined from Aug. 2023 ($1,219 Mil) to Nov. 2023 ($1,159 Mil) and declined from Nov. 2023 ($1,159 Mil) to Feb. 2024 ($1,101 Mil).

COSMOS Pharmaceutical's annual accounts payable & accrued expense declined from May. 2021 ($1,373 Mil) to May. 2022 ($1,175 Mil) but then increased from May. 2022 ($1,175 Mil) to May. 2023 ($1,303 Mil).

COSMOS Pharmaceutical Accounts Payable & Accrued Expense Historical Data

The historical data trend for COSMOS Pharmaceutical's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

COSMOS Pharmaceutical Accounts Payable & Accrued Expense Chart

COSMOS Pharmaceutical Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1,130.87

1,414.64

1,372.57

1,175.47

1,303.43

COSMOS Pharmaceutical Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1,045.44	1,303.43	1,219.00	1,158.77	1,100.87

COSMOS Pharmaceutical Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

COSMOS Pharmaceutical (COSMOS Pharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » COSMOS Pharmaceutical Corp (OTCPK:CSMYF) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

3349:Japan

Address

4 floor,10th first Fukuoka S Building Museum, Hakataekihigashi 2-chome,, Fukuoka, JPN, 812-0013

Website

http://www.cosmospc.co.jp

COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company places a strong emphasis on convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. Cosmos also operates a private grocery brand called ON 365.

COSMOS Pharmaceutical (COSMOS Pharmaceutical) Headlines

From GuruFocus

Matthews Japan Fund Reduces Stake in COSMOS

By Kyle Ferguson Kyle Ferguson • 08-12-2016

Wasatch International Growth Fund Comments on CosmosPharmaceutical Corp

By Holly LaFon Holly LaFon • 09-25-2015

Hennessy Japan Small Cap Fund Enters Macromill Holding, Boosts Tsubakimoto Chain Position

By Sydnee Gatewood • 04-05-2022

Wasatch International Growth Fund Comments on Cosmos Pharmaceutical

By Vera Yuan Vera Yuan • 10-30-2014

Hennessy Japan Small Cap Fund Adds 5 Stocks to Portfolio

By Sydnee Gatewood Sydnee Gatewood • 01-10-2020